Bruce Dalton
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 8
- Clostridium difficile and Clostridium perfringens research 3
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Thomas Louie (4 shared papers)Deana Sabuda (7 shared papers)Kevin B. Laupland (4 shared papers)Johann Pitout (3 shared papers)Duncan MacCannell (1 shared paper)Elizabeth A. Henderson (1 shared paper)John Conly (9 shared papers)Daniel B. Gregson (4 shared papers)
- Journals
- Open Forum Infectious Diseases (3 papers)Infection Control and Hospital Epidemiology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)BMC Infectious Diseases (2 papers)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Bruce Dalton
25 papers receiving 385 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 40
- Molecular Medicine 90
- Infectious Diseases 128
- Clinical Biochemistry 33
- Pharmacology 80
Countries citing papers authored by Bruce Dalton
This map shows the geographic impact of Bruce Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Dalton more than expected).
Fields of papers citing papers by Bruce Dalton
This network shows the impact of papers produced by Bruce Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Dalton. The network helps show where Bruce Dalton may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce Dalton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 78 | |
| 2 | 2019 | 47 | |
| 3 | 2008 | 46 | |
| 4 | 2010 | 36 | |
| 5 | 2014 | 30 | |
| 6 | 2013 | 22 | |
| 7 | 2015 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 14 | |
| 10 | 2015 | 12 | |
| 11 | 2013 | 12 | |
| 12 | 2023 | 11 | |
| 13 | 2015 | 9 | |
| 14 | 2020 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2010 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2020 | 3 |
About Bruce Dalton
Bruce Dalton is a scholar working on Infectious Diseases, Pharmacology, Clinical Biochemistry, Applied Microbiology and Biotechnology and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 391 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Use and Resistance (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Antibiotic Resistance in Bacteria (3 papers), Venous Thromboembolism Diagnosis and Management (1 paper) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (40 citations), Molecular Medicine (90 citations), Infectious Diseases (128 citations), Clinical Biochemistry (33 citations) and Pharmacology (80 citations). Bruce Dalton has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Thomas Louie, Deana Sabuda, Kevin B. Laupland, Johann Pitout, Duncan MacCannell, Elizabeth A. Henderson, John Conly, Daniel B. Gregson, Vikas P. Chaubey and Terry Ross. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Journal of Antimicrobial Chemotherapy, BMC Infectious Diseases and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.